Alpine Immune Sciences, Inc.
(Deutsche Boerse AG : NVLS)

( )
NVLS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.88%93.921.3%$988.55m
BIIBBiogen Inc.
2.45%229.891.3%$619.18m
AMGNAmgen Inc.
1.22%180.481.3%$474.61m
GILDGilead Sciences, Inc.
2.13%64.140.9%$448.87m
ILMNIllumina, Inc.
1.49%319.203.5%$295.43m
REGNRegeneron Pharmaceuticals, Inc.
2.80%349.992.6%$291.08m
VRTXVertex Pharmaceuticals Incorporated
1.18%174.611.9%$236.35m
ALXNAlexion Pharmaceuticals, Inc.
4.30%135.682.0%$176.60m
EXASExact Sciences Corporation
0.27%95.3925.3%$169.11m
AAgilent Technologies, Inc.
1.23%76.721.6%$147.38m
SRPTSarepta Therapeutics, Inc.
1.74%120.2214.7%$129.47m
ONCESpark Therapeutics, Inc.
0.64%111.3811.2%$116.56m
INCYIncyte Corporation
0.57%73.942.5%$97.68m
IONSIonis Pharmaceuticals, Inc.
0.72%73.868.3%$96.82m
BMRNBioMarin Pharmaceutical Inc.
-0.21%85.314.3%$92.88m

Company Profile

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.